ClinicalTrials.gov
ClinicalTrials.gov Menu

Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM (VANISH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01912534
Recruitment Status : Active, not recruiting
First Posted : July 31, 2013
Last Update Posted : February 5, 2018
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
New England Research Institutes

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : November 2018
  Estimated Study Completion Date : July 2019